Ainos (AIMD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AIMD Ainos

Watchlist

0.8668
-0.1532-15.02%

Close Jun 20 16:00 ET

0.9298
+0.0630+7.27%

Post 19:06 ET

5.64MMarket Cap-262P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Market Mover | Ainos Shares Soar 30% After the Company Reports Progress in Clinical Trials of Ainos Flora Testing Device
The company announced progress in the clinical trials of its Ainos Flora volatile organic compound point-of-care testing device.
moomoo NewsJun 14 09:40 ET · Movers
Ainos AIMD AI Ainos Flora Leverage; Bio-Path BPTH Phase 2 Data
BioPharmCatalystJun 14 08:25 ET
Express News | Ainos Inc - Clinical Trials for AI Nose-Powered Ainos Flora Device Moves Forward With 75Meaningful Case Results
ReutersJun 14 08:09 ET
Express News | Ainos Inc - Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by Nvidia Cuda
ReutersJun 14 08:09 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAinos (NASDAQ:AIMD) stock rose 54.8% to $1.27 during Friday's pre-market session. The market value of their outstanding shares is at $8.2 million. Longeveron (NASDAQ:LGVN) shares moved upwards
BenzingaJun 14 08:06 ET
Express News | Ainos Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing
ReutersMay 31 16:40 ET

Comments

Stock Region

Jun 18 01:25

Diversified Healthcare Company Reveals Clinical Trial Advancements of Its AI-Powered Technology

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA.
Ainos, Inc. (NASDAQ: AIMD, AIMDW), a diversified healthcare company focusing on novel AI-powered point-of-care testing (POCT) and VELDONA low-dose interferon therapeutics, has recently announced advancements in the clinical trials of its "Ainos Flora" device. This volatile organic compound (VOC) PO...